HER2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer

[title]
Author(s): 
Robert Bazell
Publisher: 
Random House
Publication date: 
1998

 

ISBN 0-679-45702-X  

This book recounts the history of discovery of the Her 2 receptor and of the effort, mainly by Dennis Slamon of UCLA, to develop a monoclonal antibody as a therapeutic drug to treat the cases of breast cancer that overexpress this antigen. The publisher times the release of this book with the announcement of Herceptin's FDA approval. Herceptin was the first drug produced at Genentech's Vacaville manufacturing facility.
 

 

 

Reviewed by: 
Jim DeKloe

Students

  • Learn about biotech careers
  • Find biotech programs

Learn more »

Instructors

  • Professional development
  • View curriculum

Learn more »

Industry

  • Connect with local programs
  • Find skilled workers

Learn more »